Home
About
Overview
Sharing Data
ORCID
Help
History (10)
Determinants of patient screen failures in Phase 1 clinical trials.
Airway Basal Cells Are the Key for Cystic Fibrosis Gene Therapy.
Machine Learning Model Based on Transthoracic Bioimpedance and Heart Rate Variability for Lung Fluid Accumulation Detection: Prospective Clinical Study.
Food-Grade Titanium Dioxide Particles Decreased the Bioaccessibility of Vitamin D3 in the Simulated Human Gastrointestinal Tract.
TAD disruption as oncogenic driver.
See All 10 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
TAD disruption as oncogenic driver.
Valton AL, Dekker J. TAD disruption as oncogenic driver. Curr Opin Genet Dev. 2016 02; 36:34-40.
View in:
PubMed
subject areas
Carcinogenesis
Chromatin
Gene Expression Regulation, Neoplastic
Genome, Human
Genomics
Humans
Oncogene Proteins, Fusion
Protein Domains
authors with profiles
Job Dekker PhD